About HUMIRA
HUMIRA is approved for reducing signs and symptoms in adult patients with ankylosing spondylitis (AS).
For many patients, HUMIRA can reduce the signs and symptoms of AS, such as pain in your lower back, stiffness and inflammation.
Serious infections have happened in patients taking HUMIRA. These infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some patients have died from these infections.
HUMIRA may increase the chance of getting lymphoma or other cancers.
HUMIRA can cause serious side effects including allergic reactions, hepatitis B virus reactivation, nervous system problems, blood problems, heart failure, certain immune reactions (including a lupus-like syndrome), and new or worsening psoriasis.
Please click here for additional Important Safety Information you should know about HUMIRA and discuss it with your doctor.
HUMIRA is a TNF Blocker
HUMIRA is a medicine called a TNF blocker and works by binding to TNF-alpha, a substance made by your body’s immune system. People with ankylosing spondylitis (AS) have too much TNF-alpha in their bodies. The extra TNF-alpha can attack healthy body tissue and cause inflammation in the affected areas. HUMIRA can help block the damage that too much TNF-alpha can cause and can help reduce the pain and stiffness associated with AS.
Click here for Uses and Important Safety Information you should know about HUMIRA, and discuss it with your doctor.